$1.67
2.45% today
Nasdaq, Feb 28, 05:16 pm CET
ISIN
US7743741024
Symbol
RMTI

Rockwell Medical, Inc. Stock price

$1.63
-0.43 20.87% 1M
-1.44 46.91% 6M
-0.41 20.10% YTD
+0.26 18.98% 1Y
-2.08 56.03% 3Y
-30.60 94.94% 5Y
-108.37 98.52% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.04 2.40%
ISIN
US7743741024
Symbol
RMTI
Sector

Key metrics

Market capitalization $52.68m
Enterprise Value $48.59m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 18.41
EV/Sales (TTM) EV/Sales 0.49
P/S ratio (TTM) P/S ratio 0.53
P/B ratio (TTM) P/B ratio 1.81
Revenue growth (TTM) Revenue growth 22.37%
Revenue (TTM) Revenue $98.92m
EBIT (operating result TTM) EBIT $580.00k
Free Cash Flow (TTM) Free Cash Flow $2.64m
Cash position $18.27m
EPS (TTM) EPS $-0.06
P/E forward 163.00
P/S forward 0.53
EV/Sales forward 0.48
Short interest 1.57%
Show more

Is Rockwell Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Rockwell Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Rockwell Medical, Inc. forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Rockwell Medical, Inc. forecast:

Buy
100%

Financial data from Rockwell Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
99 99
22% 22%
100%
- Direct Costs 82 82
13% 13%
83%
17 17
105% 105%
17%
- Selling and Administrative Expenses 14 14
9% 9%
14%
- Research and Development Expense 0.19 0.19
83% 83%
0%
2.77 2.77
150% 150%
3%
- Depreciation and Amortization 2.19 2.19
14% 14%
2%
EBIT (Operating Income) EBIT 0.58 0.58
107% 107%
1%
Net Profit -1.53 -1.53
84% 84%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Rockwell Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Rockwell Medical, Inc. Stock News

Neutral
Business Wire
one day ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it has been certified as a Great Place to Work for the third year in a row.
Neutral
Business Wire
8 days ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2024 on Thursday, March 20, 2025.
Neutral
Business Wire
24 days ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical adds a 510k approved single-use bicarbonate cartridge--in two sizes, 720g and 900g--to its hemodialysis concentrates portfolio.
More Rockwell Medical, Inc. News

Company Profile

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Hackensack, NJ.

Head office United States
CEO Mark Strobeck
Employees 237
Founded 1995
Website www.rockwellmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today